Neuronal Monoclonal Antibodies (NeuroMabs)
- 技術應用
- These NeuroMabs can be used to recognize endogenous target proteins in tissue and recombinant proteins with established links to disease states.
- 詳細技術說明
- In addition to the high quality monoclonal antibodies available for purchase at the UC Davis/NIH Neuromab Facility, many NeuroMab hybridomas are available for non-exclusive licensing. Please see the Neuromab Catalog (see www.neuromab.ucdavis.edu) for NeuroMabs and datasheets. Additional NeuroMabs are added as they become available. (Note: not all NeuroMabs present in the NeuroMab Catalog may be available for licensing from UC.)
- *Abstract
-
Monoclonal Antibodies Against Molecular Targets Found in the Nervous System
- *Principal Investigation
-
Name: James Trimmer
Department:
- 其他
-
Related Materials
The UC Davis NINDS/NIMH NeuroMab Hybridoma Facility
UC Davis/NIH NeuroMab FacilityRelated Technologies
Additional Technologies by these Inventors
- Anti-MMP9, Anti-Menke's Disease, and Anti-Wilson's Disease mAbs
- Anti-Mlok1 Prokaryotic Cyclic Nucleotide-Modulated Potassium Channel mAbs
Tech ID/UC Case
11194/2006-468-0
Related Cases
2006-468-0
- 國家/地區
- 美國
欲了解更多信息，請點擊 這裡
